Your browser is no longer supported. Please, upgrade your browser.
Settings
XBI SPDR S&P Biotech ETF daily Stock Chart
XBI [NYSE]
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week5.09%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.45%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter12.68%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio6.31 Perf Half Y23.26%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year29.76%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range48.89 - 72.56 Perf YTD20.73%
Dividend0.12 P/FCF- EPS past 5Y- ROI- 52W High-1.54% Beta-
Dividend %0.17% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low46.13% ATR1.29
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)63.31 Volatility1.47% 1.72%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.65 Prev Close71.19
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume4.47M Price71.44
Recom- SMA204.33% SMA503.08% SMA20011.29% Volume2,922,355 Change0.35%
Apr-26-17 03:05PM  Understanding Exelixiss Operating Expense Expectations for 1Q17 Market Realist
Apr-25-17 02:14PM  Should You Worry About A Trump Trap? Benzinga
01:24PM  Story Stocks from Briefing.com Briefing.com
08:58AM  Biogen's Excellent Q1 Bodes Well for Biotech Investopedia
Apr-24-17 05:36PM  Trump's First 100 Days: Is the "Trump Trade" Already Dead? Zacks
Apr-20-17 09:25AM  Why biotech stocks are a healthy bet in a sickly broader market MarketWatch
Apr-12-17 01:59PM  Biotech ETFs To Consider Ahead of Earnings Season Barrons.com
Apr-11-17 01:05PM  The Larger Aims of Obamacare: An Overview Market Realist
Apr-01-17 02:13PM  Tax reform could be a back door for another Republican Obamacare repeal attempt MarketWatch
02:13PM  Tax reform could be a back door for another Republican Obamacare repeal attempt at MarketWatch
Mar-30-17 05:00PM  How to trade gridlock in DC: 4 plays CNBC Videos
04:03PM  Is Rising Consumer Sentiment Helping the Market Rally in 2017? Market Realist
04:03PM  Is Rising Consumer Sentiment Helping the Market Rally in 2017?
Mar-28-17 05:00PM  5 ways to trade today's market rally CNBC Videos
02:37PM  Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher? Investor's Business Daily
02:37PM  Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher?
Mar-27-17 08:23AM  What Trump can do to undermine Obamacare, now that the GOP health bill has failed MarketWatch
08:23AM  What Trump can do to undermine Obamacare, now that the GOP health bill has failed at MarketWatch
Mar-24-17 07:05PM  4 ways to trade the cancelled healthcare vote CNBC
07:05PM  4 ways to trade the cancelled healthcare vote at CNBC
04:39PM  Trump Pulls the Healthcare Bill; Market Feels the Pain Barrons.com
04:39PM  Trump Pulls the Healthcare Bill; Market Feels the Pain at Barrons.com
Mar-22-17 10:37AM  Recent Developments for Ionis Pharmaceuticals Market Realist
10:37AM  Recent Developments for Ionis Pharmaceuticals
Mar-21-17 12:08PM  Biotechnology Gets A Shot In the Arm at Barrons.com
12:05PM  Understanding Ionis Pharmaceuticals 2016 Revenue Stream
Mar-20-17 12:46PM  Biotech firm says its closing in on the cancer that killed Steve Jobs at MarketWatch
Mar-16-17 12:53PM  Biogen Weighs On Biotech ETFs; Time to Bail? at Barrons.com
Mar-15-17 12:10PM  Wednesdays Biggest Biopharma Movers
Mar-13-17 05:46PM  Time to Buy Biotech ETFs?
05:46PM  Time to Buy Biotech ETF?
Mar-10-17 02:22PM  Trump Expected to Name Scott Gottlieb as FDA Commissioner
02:17PM  Trump administration expected to name VC partner Gottlieb to head FDA at MarketWatch
11:32AM  Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump
Mar-09-17 04:05PM  These Health Care ETFs Could Be in Play with the GOP's ACA Repeal
04:09AM  Trumps Obamacare Lite presents opportunities and perils for investors at MarketWatch
Mar-07-17 04:05PM  Stocks Fall for Day Two as Trump Targets Health Care Sector
02:57PM  Biotech: When @RealDonaldTrump Shows Up at Barrons.com
02:24PM  Stock market loses ground as energy shares weigh at MarketWatch
01:31PM  S&P 500 challenges the breakout point amid (still) bullish longer-term backdrop at MarketWatch
11:17AM  These stocks are getting whacked after the GOP unveils its Obamacare replacement
10:47AM  Are You In The Best Health Care ETF? GOP Moves To Replace ObamaCare
09:16AM  Pharma and biotech stocks slump after President Trump tweets about lowering drug prices at MarketWatch
Mar-02-17 02:00PM  Trump's Immigration Plans an Overhang on Biotech ETFs?
Mar-01-17 05:32PM  Did Biotech Get a Presidential Pardon? at Barrons.com
Feb-28-17 01:06PM  Incytes Revenue Trend for 2016
07:40AM  How Do Analysts View Alnylam Pharmaceuticals in 2017?
Feb-27-17 05:08PM  Health care best Trump trade?
03:38PM  Biotech Surges. Is the Sector Breaking Out? at Investopedia
12:02PM  Exelixis shares jump after team up with Bristol-Myers on cancer trials at CNBC
Feb-26-17 08:26PM  Zacks Podcast Highlights: How Do Leveraged and Inverse ETFs Work?
08:35AM  The Most Undervalued Sector in the Stock Market Today at Motley Fool
Feb-23-17 11:45AM  ETF Industry to Get a Product on Marijuana?
Feb-21-17 08:09AM  The case for buying the biotech bounce at CNBC
Feb-17-17 11:34AM  Biotech ETF Investors are Still on the Sidelines at Investopedia
07:44AM  Biotech Stock Mailbag: Bulls Love a Distracted Trump, Protalix, Acadia, Sarepta
Feb-10-17 10:17AM  Why Gilead's Disastrous Forecast is Good News for Biotech at Barrons.com
Feb-09-17 01:16PM  Leveraged ETFs: How Are They Built and What's Hot Now?
Feb-08-17 08:26AM  Oppenheimer: Currency FX on Rx at Barrons.com
Feb-05-17 09:47AM  5 reasons to bank on biotech stocks now at MarketWatch
Feb-03-17 04:49PM  The Week Ahead: Trump's 1st Quarter - Pain Or Gain? at Forbes
Feb-01-17 07:00AM  Trader's Daily Notebook: Post-Election Rally in Small-Caps Isn't Over Yet
Jan-31-17 05:28PM  Making pharma great again?
05:09PM  Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting
04:14PM  Wall Street Ends January on Weak Note as Washington Division Deepens
01:31PM  Volatile biotech trade illustrates Trumps ability to shift sentiment on a dime at MarketWatch
01:08PM  Biotech Stocks Gain on Latest Trump Drug Price Statements
10:57AM  President Trump Doubles Down On Healthcare Criticism, Says Drug Prices Are 'Astronomical'
10:37AM  Trump, at Biopharma Meeting, Pledges to 'Streamline' FDA, Cut Regulations but Wants Lower Prices
Jan-27-17 04:30PM  What Lies Ahead for Biotech ETFs in Trump Era?
Jan-26-17 01:21PM  Biotech ETFs: Is It Time To Buy? at Barrons.com
Jan-23-17 02:16PM  Top Biotech Stocks to Buy in 2017 at Motley Fool
Jan-18-17 10:03AM  4 Top Biotech Mutual Funds for 2017
06:00AM  Trump Foreshadows a Bleak Outlook for Biotech at Investopedia
Jan-17-17 11:16AM  Biotech ETFs: When Will The Pain End? at Barrons.com
Jan-16-17 10:55AM  Fidelity Biotech Fund: Better than the Index? at Motley Fool
Jan-12-17 12:01PM  Biotech ETFs Continue To Bleed at Barrons.com
12:00PM  Trump's First Press Conference Puts These ETFs in Focus
11:34AM  Trump's Remarks Show Why Pharma Sector Is 'Barely Investable': More Squawk From Jim Cramer
07:32AM  5 Things You Must Know Before the Market Opens Thursday
06:35AM  Donald Trump Whacks European Stocks
04:47AM  European Pharma Shares Hammered After Trump Press Conference Attack
Jan-11-17 04:27PM  Dow moves within 50 points of 20,000 after Trump news conference at MarketWatch
04:16PM  Nasdaq Posts Another Record Close in Unpredictable Trump-Triggered Trading Session
03:58PM  P.M. Funds Roundup: Mexico, Biotech ETFs Get Trumped; Is It RIP For Bitcoin ETF? at Barrons.com
03:16PM  Stocks Back to Gains in Unsettled Trade After Trump News Conference
02:36PM  Good Enough? Trump Outlines Plans to Separate From Business but Will Not Divest Holdings
02:14PM  Trump Takes Aim at Pharma but Investors Shouldn't Panic
12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes
12:09PM  Biotech, Pharma ETFs Sink; Trump Promises "Bidding Procedures" at Barrons.com
11:30AM  Biotech ETFs fall as Trump says more bidding needed on drugs at MarketWatch
Jan-09-17 09:06AM  How Was Incytes Profitability in 3Q16?
Jan-06-17 12:27PM  The 'Super Bowl' for health care investors
09:07AM  What Were Incytes Revenue Streams in 3Q16?
03:26AM  These stock-market sectors will be the most volatile in 2017: Goldman Sachs at MarketWatch
Jan-05-17 01:25PM  Biotech Stocks Find Reprieve in Options at The Wall Street Journal
Dec-29-16 07:36AM  United Therapeutics Robust Research Pipeline
Dec-28-16 07:02PM  Zacks Podcast Highlights: Immunotherapy Stocks 101: What Biotech Investors Need to Know Now
10:55AM  Celgene Winding Up for 2017 Breakout (CELG, IBB) at Investopedia
Dec-23-16 08:59AM  Your first trade for Friday, December 23 at CNBC
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.